Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 485.00
Bid: 480.00
Ask: 490.00
Change: -2.00 (-0.41%)
Spread: 10.00 (2.083%)
Open: 487.00
High: 489.00
Low: 485.00
Prev. Close: 487.00
BPM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investee Company Update disposal by LEBC of Aspira

13 Nov 2023 09:42

RNS Number : 2421T
B.P. Marsh & Partners PLC
13 November 2023
 

13 November 2023

B.P. Marsh & Partners Plc

("B.P. Marsh", the "Company" or the "Group")

 

Investee Company Update - disposal by LEBC Holdings Limited of Aspira Corporate Solutions Limited

 

B.P. Marsh & Partners Plc (AIM:BPM), the specialist private equity investor in early stage financial services businesses, is pleased to announce that LEBC Holdings Limited ("LEBC") has conditionally sold Aspira Corporate Solutions Limited ("Aspira"), a wholly-owned subsidiary of LEBC, to Titan Wealth Holdings Limited ("Titan Wealth"), the discretionary fund management/wealth and asset management business (the "Transaction").

 

Background to the Investment

 

B.P. Marsh invested in LEBC in 2007, when its main operating subsidiary was LEBC Group Limited ("LEBC Group"), the national independent financial advisory ("IFA") firm. In 2017, LEBC acquired Aspira, the Bristol-based IFA founded in 2003 by its CEO, Derek Miles.

 

B.P. Marsh has a 59.34% shareholding in LEBC (the only majority position held within the current portfolio), the business of which has grown to provide pensions and investment advice to more than 1,600 corporate entities and over 15,000 individuals with circa £4 billion of assets under advice.

 

As previously announced, over the past three years LEBC has gone through a restructuring process led by Derek Miles and his management team in close consultation with the FCA. As announced by the Company on 9 August 2023, this process resulted in the consolidation of LEBC Group into Aspira, bringing the two businesses together under one brand with the intention of delivering an enhanced service for individual and corporate clients.

 

B.P. Marsh has been invested in LEBC for over 15 years and has supported the business through many changes in the advice market. The new ownership under Titan Wealth offers an exciting future for Aspira, and the Company wishes all stakeholders every success.

 

The Transaction

 

On 10 November 2023, LEBC agreed to sell 100% of Aspira to Titan Wealth, subject to regulatory approval.

 

LEBC will receive proceeds of sale over a three year earn-out period. The Group's expectation is that this will be at least in line with the Company's most recent published valuation of LEBC as at 31 July 2023, of £15,947,000. Additionally, the Group expects to receive repayment in full of its outstanding loans with LEBC, a total of £3.3m.

 

The Transaction will also allow LEBC to meet its obligations, as agreed with the FCA, regarding historical defined benefit pension transfer advice.

 

Commenting on the Transaction, Derek Miles, Chief Executive Officer of Aspira, said:

 

"I would like to thank all at B.P. Marsh for their longstanding support of LEBC and Aspira since their original investment back in 2007. Since I became CEO of the business in 2020, I have worked very closely with B.P. Marsh, who supported me fully in a comprehensive restructuring of the business, which has led to this eventual sale.

 

Such a sale has safeguarded the future of Aspira, as by combining our strengths and resources with Titan Wealth, we will be able to provide even greater value to our customers and further enhance our pensions advisory service. This would not have been possible without the full support of B.P. Marsh."

 

Oliver Bogue, Non-Executive Chairman of LEBC and B.P. Marsh Nominee Director on the Board of LEBC and Aspira, stated:

 

"It has been a pleasure to work with Derek Miles and the team at Aspira, seeing the business through this period of transformational change. This sale marks an exciting new chapter for Aspira, and is a natural next step in their progression.

 

At B.P. Marsh's current valuation, this transaction produces an Internal Rate of Return of 8.33%. This investment outlines B.P. Marsh's ability to support a business in the long term through uncertain times, safeguarding shareholder value. Such a result is also testament to Derek Miles and his team, given the fundamental changes the business has been though over the past number of years."

 

 

 

For further information:

 

B.P. Marsh & Partners Plc

www.bpmarsh.co.uk

Brian Marsh OBE

+44 (0)20 7233 3112

Nominated Adviser & Broker

Panmure Gordon

Atholl Tweedie / Stephen Jones / Amrit Mahbubani / Ailsa MacMaster

+44 (0)20 7886 2500

Financial PR & Investor Relations

Tavistock

bpmarsh@tavistock.co.uk

Simon Hudson / Tim Pearson / Katie Hopkins

+44 (0)20 7920 3150

 

Notes to Editors:

B.P. Marsh's current portfolio contains fourteen companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk.

 

Since formation over 30 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for approaching ten years.

 

 

- Ends - 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISBJBLTMTJBMLJ
Date   Source Headline
22nd Aug 20233:19 pmRNSTransaction in Own Shares
21st Aug 20234:12 pmRNSTransaction in Own Shares
18th Aug 20235:06 pmRNSTransaction in Own Shares
17th Aug 20235:25 pmRNSTransaction in Own Shares
16th Aug 202311:41 amRNSTransaction in Own Shares
15th Aug 202311:54 amRNSTransaction in Own Shares
11th Aug 202312:21 pmRNSTransaction in Own Shares
10th Aug 20239:28 amRNSTransaction in Own Shares
9th Aug 20233:24 pmRNSTransaction in Own Shares
9th Aug 20231:44 pmRNSInvestee Company Update - LEBC
8th Aug 20235:23 pmRNSHolding(s) in Company
7th Aug 20234:25 pmRNSShare Buy-Back Policy
4th Aug 20234:00 pmRNSPDMR and Director Dealings
3rd Aug 20238:58 amRNSTransaction in Own Shares
1st Aug 20235:00 pmRNSTransaction in Own Shares
31st Jul 20232:17 pmRNSTransaction in Own Shares
26th Jul 20234:07 pmRNSResult of AGM
25th Jul 20234:22 pmRNSTransaction in Own Shares
25th Jul 20233:25 pmRNSTransaction in Own Shares
21st Jul 20231:17 pmRNSTransaction in Own Shares
19th Jul 20233:44 pmRNSTransaction in Own Shares
18th Jul 202311:36 amRNSTransaction in Own Shares
11th Jul 20234:02 pmRNSTransaction in Own Shares
10th Jul 20232:41 pmRNSTransaction in Own Shares
30th Jun 202312:05 pmRNSDirector/PDMR Shareholding
30th Jun 20237:00 amRNSNotice of AGM
27th Jun 20233:06 pmRNSTransaction in Own Shares
26th Jun 202311:43 amRNSTransaction in Own Shares
22nd Jun 202310:59 amRNSTransaction in Own Shares
21st Jun 20231:10 pmRNSNew Investment – Pantheon Specialty Limited
21st Jun 202311:53 amRNSTransaction in Own Shares
19th Jun 20231:15 pmRNSTransaction in Own Shares
13th Jun 202312:08 pmRNSDividend payment date correction
13th Jun 20237:00 amRNSFinal Results
7th Jun 20235:39 pmRNSHolding(s) in Company
6th Jun 20234:05 pmRNSTransaction in Own Shares
6th Jun 20237:00 amRNSUse of Proceeds of Sale & Strategy Update
30th May 202310:18 amRNSTransaction in Own Shares
26th May 20239:40 amRNSTransaction in Own Shares
25th May 20233:11 pmRNSTransaction in Own Shares
23rd May 20232:49 pmRNSNotice of Annual Results and Investor Presentation
23rd May 20237:00 amRNSSale of Shareholding in Kentro Capital Limited
15th May 202310:59 amRNSTransaction in Own Shares
28th Apr 20235:11 pmRNSTransaction in Own Shares
28th Apr 20232:01 pmRNSNew Investment
26th Apr 20234:26 pmRNSTransaction in Own Shares
25th Apr 20235:42 pmRNSTransaction in Own Shares
25th Apr 20237:00 amRNSShare Buy-Back Programme Update
20th Apr 20234:49 pmRNSDirector/PDMR Shareholding
20th Apr 20233:10 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.